| Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells CL Scott, F Zheng, P De Baetselier, L Martens, Y Saeys, S De Prijck, ... Nature communications 7 (1), 10321, 2016 | 973 | 2016 |
| Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB C Porta, M Rimoldi, G Raes, L Brys, P Ghezzi, D Di Liberto, F Dieli, ... Proceedings of the National Academy of Sciences 106 (35), 14978-14983, 2009 | 815 | 2009 |
| Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages G Raes, P De Baetselier, W Noël, A Beschin, F Brombacher, ... Journal of leukocyte biology 71 (4), 597-602, 2002 | 617 | 2002 |
| Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion JA Van Ginderachter, K Movahedi, GH Ghassabeh, S Meerschaut, ... Immunobiology 211 (6-8), 487-501, 2006 | 503 | 2006 |
| Alternatively activated macrophages during parasite infections W Noël, G Raes, GH Ghassabeh, P De Baetselier, A Beschin Trends in parasitology 20 (3), 126-133, 2004 | 399 | 2004 |
| Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells G Raes, R Van den Bergh, P De Baetselier, GH Ghassabeh The Journal of immunology 174 (11), 6561-6562, 2005 | 382 | 2005 |
| Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages K Movahedi, S Schoonooghe, D Laoui, I Houbracken, W Waelput, ... Cancer research 72 (16), 4165-4177, 2012 | 357 | 2012 |
| Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation G Raes, L Brys, BK Dahal, J Brandt, J Grooten, F Brombacher, G Vanham, ... Journal of leukocyte biology 77 (3), 321-327, 2005 | 316 | 2005 |
| Functional relationship between tumor-associated macrophages and macrophage colony-stimulating factor as contributors to cancer progression D Laoui, E Van Overmeire, P De Baetselier, JA Van Ginderachter, G Raes Frontiers in immunology 5, 489, 2014 | 261 | 2014 |
| Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection L Brys, A Beschin, G Raes, GH Ghassabeh, W Noël, J Brandt, ... The Journal of Immunology 174 (10), 6095-6104, 2005 | 206 | 2005 |
| FIZZ1 and Ym as tools to discriminate between differentially activated macrophages G Raes, W Noël, A Beschin, L Brys, P De Baetselier, GG Hassanzadeh Journal of Immunology Research 9 (3), 151-159, 2002 | 203 | 2002 |
| Identification of a common gene signature for type II cytokine–associated myeloid cells elicited in vivo in different pathologic conditions G Hassanzadeh Ghassabeh, P De Baetselier, L Brys, W Noël, ... Blood 108 (2), 575-583, 2006 | 200 | 2006 |
| 131I-labeled anti-HER2 camelid sdAb as a theranostic tool in cancer treatment M D'Huyvetter, J De Vos, C Xavier, M Pruszynski, YGJ Sterckx, S Massa, ... Clinical Cancer Research 23 (21), 6616-6628, 2017 | 195 | 2017 |
| PET imaging of macrophage mannose receptor–expressing macrophages in tumor stroma using 18F-radiolabeled camelid single-domain antibody fragments A Blykers, S Schoonooghe, C Xavier, K D’hoe, D Laoui, M D’Huyvetter, ... Journal of Nuclear Medicine 56 (8), 1265-1271, 2015 | 171 | 2015 |
| Myeloid‐derived suppressor cells in parasitic infections JA Van Ginderachter, A Beschin, P De Baetselier, G Raes European journal of immunology 40 (11), 2976-2985, 2010 | 166 | 2010 |
| In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT I Vaneycken, J Govaert, C Vincke, V Caveliers, T Lahoutte, ... Journal of Nuclear Medicine 51 (7), 1099-1106, 2010 | 162 | 2010 |
| Expression of the inhibitory CD200 receptor is associated with alternative macrophage activation N Koning, M Van Eijk, W Pouwels, MSM Brouwer, D Voehringer, ... Journal of innate immunity 2 (2), 195-200, 2010 | 157 | 2010 |
| Systemic reprogramming of monocytes in cancer M Kiss, AA Caro, G Raes, D Laoui Frontiers in oncology 10, 1399, 2020 | 148 | 2020 |
| Theranostics in immuno-oncology using nanobody derivatives Q Lecocq, Y De Vlaeminck, H Hanssens, M D'Huyvetter, G Raes, ... Theranostics 9 (25), 7772, 2019 | 146 | 2019 |
| Nanobodies as tools for in vivo imaging of specific immune cell types K De Groeve, N Deschacht, C De Koninck, V Caveliers, T Lahoutte, ... Journal of Nuclear Medicine 51 (5), 782-789, 2010 | 145 | 2010 |
